Trends in pharmaceutical targeting of clinical indications: 1930-2013.


An analysis of FDA-approved new molecular entities (NMEs) reveals trends in therapeutic applications. Four groupings (infectious diseases, cardiovascular diseases, autoimmune/inflammatory diseases and cancer) capture more than 60% of NMEs. Infectious diseases are the most targeted indications. Near the turn of the new millennium, the rate of new approvals… (More)
DOI: 10.1016/j.drudis.2014.05.021


  • Presentations referencing similar topics